Jazz Pharmaceuticals Completes Acquisition of Chimerix
April 22, 2025
Addition of dordaviprone strengthens Jazz’s late-stage oncology pipeline and reinforces commitment to addressing rare diseases with significant unmet need Jazz Pharmaceuticals announced the successful completion